Asiastrategy is a US-listed company in the diversified financial services industry. Its financial year ends in December.
Loading chart…
Third-party market data · may be delayed
Under review: data-quality checks not passed.
Under review: data-quality checks not passed. We'll show the comparison once resolved.
Asiastrategy valuation: adjust assumptions and compare models →
What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.
Revenue for the twelve months was $11m. The diluted share count is up 19.5% on a year earlier, which dilutes existing holders. It passes 3 of our 6 financial-health checks.
Our model value for Asiastrategy is under review, so past values are not shown until it is resolved.
Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.
Asiastrategy's trailing-twelve-month revenue fell 37.7% year on year, with a free-cash-flow margin of -39.4%.
Current signal Balance sheet growing far ahead of sales: Total assets grew 499% year over year while revenue fell 38% — the balance sheet is expanding 537 points faster than the business it supports.
Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.
Nothing in Asiastrategy's latest figures clears our strength thresholds.
Loading chart…
Third-party market data · may be delayed
Company announcements, filed results and changes that matter to shareholders.
No recent updates are available for SORA from the sources we follow. See filings →
| At fiscal year end | 2025 |
|---|---|
| Share price | $3.05 |
| Market value | $75m |
| + Net debt (− = net cash) | $10m |
| Enterprise value | $85m |
| Multiples | |
| Price / sales | 6.8x |
| Price / earnings | 6.1x |
| Price / free cash flow | — |
| EV / EBITDA | — |
Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Medium.
No analyst estimates are published for Asiastrategy: too few analysts cover it.
| Calendar year | 2026 to date |
|---|---|
| Return | |
| SORA | −20% |
| Industry peers (median) | −34% |
| S&P 500 | +11% |
| Months that ended higher | |
| SORA | 64% |
| S&P 500 | 46% |
| Largest fall from a high during the year | |
| SORA | −50% |
| S&P 500 | −9% |
Worst fall since April 2, 2025: 87% from May 28, 2025 to July 15, 2026. Getting back needed a 686% gain, and the shares have not yet recovered.
Source: SEC EDGAR filings. Retrieved Invalid Date.
| Period | Revenue (TTM) |
|---|---|
| FY22 Q4 | $14.2M |
| FY23 Q4 | $18.8M |
| FY24 Q4 | $17.6M |
| FY25 Q4 | $11M |
Source: SEC EDGAR filings. Retrieved Invalid Date.
| Period | Operating margin (TTM) |
|---|---|
| FY22 Q4 | 1.4% |
| FY23 Q4 | 2.8% |
| FY24 Q4 | 1.3% |
| FY25 Q4 | -14.3% |
| Fiscal year | 2022 Dec 2022 | 2023 Dec 2023 | 2024 Dec 2024 | 2025 Dec 2025 |
|---|---|---|---|---|
| Income | ||||
| Revenue | 14 | 19 | 18 | 11 |
| Gross profit | 1 | 1 | 1 | 0 |
| EBITDA | 0 | 1 | 0 | −2 |
| Operating income | 0 | 1 | 0 | −2 |
| Net income | 0 | 0 | −0 | 12 |
| Diluted EPS | $0.00 | $0.01 | −$0.00 | $0.50 |
| Growth (year on year) | ||||
| Revenue | — | +32.3% | −6.4% | −37.7% |
| EBITDA | — | — | −56.6% | — |
| Operating income | — | — | −56.6% | — |
| Margins | ||||
| Gross margin | 8.9% | 7.3% | 8.0% | 3.5% |
| EBITDA margin | 1.4% | 2.8% | 1.3% | −14.3% |
| Operating margin | 1.4% | 2.8% | 1.3% | −14.3% |
| Net margin | 0.5% | 1.0% | −0.2% | 111.9% |
| Free-cash-flow margin | — | — | — | −39.4% |
| Cash flow | ||||
| Cash from operations | −2 | 1 | −0 | −4 |
| Capital spending | — | — | — | 0 |
| Free cash flow | — | — | — | −4 |
| Balance sheet | ||||
| Cash | 1 | 1 | 3 | 1 |
| Total debt | 0 | — | — | 11 |
| Net debt (negative = net cash) | −1 | −1 | −3 | 10 |
| Diluted shares | 20m | 20m | 21m | 25m |
| Returned to shareholders | ||||
| Dividends | 0 | — | — | — |
| Total returned | 0 | — | — | — |
| Last 12 months unless stated | SORA | ABTS | RMCO | YDKG | ZNB | VIP | Median |
|---|---|---|---|---|---|---|---|
| Revenue, last 12 months | $11m | $9m | $6m | $28m | $28m | $51m | $28m |
| Revenue growth, last 12 months | −37.7% | 36.0% | 133.5% | >999% | 225.0% | −14.1% | 25.8% |
| Revenue growth, 3-year average | — | — | — | −32.8% | — | −9.1% | −9.1% |
| Revenue growth, latest quarter | — | — | 38.0% | — | — | −73.7% | 25.1% |
| Gross margin | 3.5% | 40.3% | 11.1% | −2.5% | −18.6% | — | 11.1% |
| Operating margin | −14.3% | 40.3% | −5.1% | −160.1% | −66.0% | −24.0% | −107.0% |
| Operating margin, 3-year average | — | — | −20.1% | −354.9% | — | −19.2% | −144.9% |
| Net margin | 111.9% | −31.4% | −14.5% | −99.7% | −555.2% | 1.0% | −31.4% |
| Cash from operations / revenue | −39.3% | 15.5% | −2.3% | 25.1% | −24.5% | −39.7% | −24.5% |
| Free-cash-flow margin | −39.4% | −18.5% | −2.4% | −7.6% | −58.9% | −57.9% | −39.4% |
| Free-cash-flow margin, 3-year average | — | — | −9.3% | −113.1% | — | −49.1% | −35.7% |
| Stock pay / revenue | — | 2.9% | — | 3.3% | 2.3% | 1.9% | 2.1% |
| Change in share count | 19.5% | 0.0% | 0.3% | >999% | >999% | 26.1% | 19.5% |
| Manager | Value | Shares | Share of 13F value | Shares QoQ |
|---|---|---|---|---|
| Geode Capital Management, LLC | $29,164 | 15K | 42.5% | 0.0% |
| Wedbush Securities Inc | $25,000 | 13K | 36.5% | ▼ 2.0% |
| Tower Research Capital LLC (TRC) | $4,825 | 3K | 7.0% | ▲ 78.6% |
| UBS Group AG | $4,777 | 2K | 7.0% | ▲ 97.4% |
| Efg International AG | $2,895 | 2K | 4.2% | 0.0% |
| Blackrock, Inc. | $1,889 | 1K | 2.8% | 0.0% |
From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Asiastrategy's complete shareholder register. Values are as reported by the filers .
From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.
| Data | Last updated | Source |
|---|---|---|
| Share price | Exchange closing prices | |
| News and updates | Company releases and SEC 8-K filings | |
| Analyst estimates | Aggregated analyst estimates | |
| Valuation and scores | Our models, from the filed figures |
New research on the companies we cover arrives in the weekly email. Free, one email a week.
